dipyridamole has been researched along with Petechiae in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Petechiae: Pinhead size (3 mm) skin discolorization due to hemorrhage.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kalowski, S | 1 |
Kincaid-Smith, P | 1 |
1 other study available for dipyridamole and Petechiae
Article | Year |
---|---|
Glomerulonephritis in Henoch-Schölein syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anticoagulants; Australia; Biopsy; Child; Dipyrida | 1973 |